d.szymanski
TL3 Wiki editor · Gdańsk, PL
Structure and headings. A page nobody can navigate is a page nobody reads.
Joined 18 December 2024 · last posted 1d · groups: wiki-editors
137Posts here
2Topics
2Solutions
5.9kLikes received
3.7kLikes given
31Badges
469Days visited
16kPosts read
Stated areas
Recent activity
Full stream-
Gradient steepness and apparent purity: a worked comparison — the long version Replied, post #3 · Analytics › HPLC & UHPLC · 27 Jul 2026 · 5 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #121 · Outcomes › Body composition · 24 Jul 2026 · 14 likes Worth separating two things that post #117 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
SURPASS-2 and the comparator dose question that will not go away — what changed since Replied, post #6 · Compounds › Tirzepatide · 20 Jul 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
What a certificate commits its issuer to — the long version Replied, post #25 · Analytics › COA interpretation · 20 Jul 2026 · 0 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #28 · Lounge › Off topic · 18 Jul 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #38 · Compounds › Secretagogues & GH axis · 13 Jul 2026 · 24 likes CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently and persists for days. The version without it does not persist.…
-
What a certificate commits its issuer to Replied, post #17 · Analytics › COA interpretation · 12 Jul 2026 · 17 likes post #16 is right about the mechanism and I think understates the practical bit. Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A…
-
What is genuinely unknown about long-term amylin agonism Replied, post #3 · Compounds › Cagrilintide & amylin analogues · 4 Jul 2026 · 2 likes Cagrilintide alone is discussed less than in combination because the published data is almost entirely from combination trials. The phase 2 combination data was…
-
Coming back to: A structured critique template this community uses Replied, post #47 · Evidence › Study critique · 1 Jul 2026 · 9 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Coming back to: Swirling versus inverting versus leaving it alone Replied, post #24 · Practice › Reconstitution · 28 Jun 2026 · 29 likes This follows post #21 rather than contradicting it. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2…
-
[2026 update] Why 99.2% and 97.8% on the same lot can both be correct Replied, post #4 · marked as the solution · Analytics › HPLC & UHPLC · 27 Jun 2026 · 8 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
-
Personal or family history of medullary thyroid carcinoma Replied, post #10 · Safety › Contraindications · 24 Jun 2026 · 17 likes Severe renal impairment (eGFR
Maintains 2 documents
- Growth-hormone-releasing peptides (GHRP class) — referenceReview due 14 Mar 2027
- Retatrutide phase 2 (type 2 diabetes) — trial digestReview due 1 Nov 2026